Atossa Therapeutics Share Price (NASDAQ: ATOS)
$0.76
▲
0.01
(1.33%)
Last updated on
Check the interactive Atossa Therapeutics Stock chart to analyse performance
Atossa Therapeutics stock performance
as on August 30, 2025 at 1:28 am IST
- Today's Low:$0.75Today's High:$0.77
1.08%
Downside
Day's Volatility :1.73%
Upside
0.65%
- 52 Weeks Low:$0.5552 Weeks High:$1.66
27.29%
Downside
52 Weeks Volatility :66.71%
Upside
54.22%
Atossa Therapeutics Stock Returns
Atossa Therapeutics Inc Key Stats
Check Atossa Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Atossa Therapeutics Stock including INR - Dollar returns
The Atossa Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Atossa Therapeutics investment value today
Current value as on today
₹60,759
Returns
Returns from Atossa Therapeutics Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Atossa Therapeutics Stock
Global Institutional Holdings in Atossa Therapeutics Inc
Name
Holdings %
BlackRock Inc
7.45%
Vanguard Group Inc
4.52%
Geode Capital Management, LLC
2.20%
Renaissance Technologies Corp
1.44%
State Street Corp
1.34%
Northern Trust Corp
0.75%
Analyst Recommendation on Atossa Therapeutics Stock
Buy
90%Buy
10%Hold
0%Sell
Based on 10 Wall street analysts offering stock ratings for Atossa Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Atossa Therapeutics Share Price Target
What analysts predicted
Upside of 640.13%
Target:
$5.63
Current:
$0.76
Atossa Therapeutics share price target is $5.63, a slight Upside of 640.13% compared to current price of $0.76 as per analysts' prediction.
Atossa Therapeutics Stock Insights
Price Movement
In the last 1 month, ATOS stock has moved down by -12.9%ATOS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 114.5%ATOS vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 130.9%
Atossa Therapeutics Technicals Summary
Sell
Neutral
Buy
Atossa Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Atossa Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -8.93% | 2.5% | -43.32% | -16.99% | -69.74% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | 0.0 | -0.24 | -0.42 | -0.25 | NA | 0.45 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $98.5M | -69.74% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Atossa Therapeutics Inc
What is Atos?
Atossa Therapeutics, Inc., popularly called Atos, is a clinical-stage biopharmaceutical company focused on developing innovative treatments in oncology, particularly for breast cancer. It was founded in 2008 and is headquartered in Seattle, Washington. The company was formerly known as Atossa Genetics Inc. before rebranding to Atossa Therapeutics, Inc. in January 2020.
What does Atos do?
Atossa develops targeted therapies for breast cancer and related conditions with a focus on areas of unmet medical need. Its lead candidate, oral (Z)-endoxifen, is an active metabolite of tamoxifen currently in Phase II clinical trials for breast cancer treatment and prevention. The company is also advancing immunotherapy programs, including chimeric antigen receptor (CAR) therapies, to expand its pipeline into other oncology areas.
Atos Products and Programs
| Products/Programs | Description |
| Oral (Z)-Endoxifen | Phase II-stage drug for treatment and prevention of hormone-receptor positive breast cancer |
| Immunotherapy Programs | Development of CAR-based therapies to target cancerous cells |
| Oncology R&D | Focus on novel, targeted treatments for breast cancer and related indications |
| Clinical Trials | Multiple Phase I/II trials evaluating safety and efficacy of pipeline therapies |
Key Management of Atossa Therapeutics Inc
Important FAQs about investing in ATOS Stock from India :
What is Atossa Therapeutics share price today?
Atossa Therapeutics share price today is $0.76 as on at the close of the market. Atossa Therapeutics share today touched a day high of $0.77 and a low of $0.75.
What is the 52 week high and 52 week low for Atossa Therapeutics share?
Atossa Therapeutics share touched a 52 week high of $1.66 and a 52 week low of $0.55. Atossa Therapeutics stock price today i.e. is closed at $0.76, lower by 54.22% versus the 52 week high.
How to invest in Atossa Therapeutics Stock (ATOS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Atossa Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Atossa Therapeutics Shares that will get you 1.9737 shares as per Atossa Therapeutics share price of $0.76 per share as on August 30, 2025 at 1:28 am IST.
What is the minimum amount required to buy Atossa Therapeutics Stock (ATOS) from India?
Indian investors can start investing in Atossa Therapeutics (ATOS) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Atossa Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Atossa Therapeutics share’s latest price of $0.76 as on August 30, 2025 at 1:28 am IST, you will get 13.1579 shares of Atossa Therapeutics. Learn more about
fractional shares .
What are the returns that Atossa Therapeutics has given to Indian investors in the last 5 years?
Atossa Therapeutics stock has given -69.74% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%